Three Seasons Wealth’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Three Seasons Wealth's BMY Position: Q2 2026 in Review
Three Seasons Wealth increased its Bristol-Myers Squibb (BMY) stake by 63% in Q2 2026, buying an estimated $849K and bringing the position to 38,187 shares worth $2.2M. The position accounts for 0.2% of the portfolio, ranked #39.
Three Seasons Wealth first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Three Seasons Wealth held 38,187 shares of Bristol-Myers Squibb worth $2.2M as of Q2 2026.
- Three Seasons Wealth bought 14,778 Bristol-Myers Squibb shares in Q2 2026, an estimated $849K.
- Bristol-Myers Squibb made up 0.2% of Three Seasons Wealth's portfolio in Q2 2026, its #39 holding.
- Three Seasons Wealth first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Three Seasons Wealth's 13F filing for Q2 2026, filed 13 Aug 2026.